SCHEMBL29593255

SCHEMBL29593255

Cc1cc(F)ccc1-c1nc(S(C)(=O)=O)nc(Nc2ccccc2F)c1C=O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.39
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ZAP70 P43403 1/20 0.36
RXFP1 Q9HBX9 2/20 0.33
CTSA P10619 1/20 0.33
MAPK3 P27361 1/20 0.33
BRD4 O60885 1/20 0.33
SDHB P21912 1/20 0.33
LRRK2 Q5S007 1/20 0.32
PTGS2 P35354 1/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
PKM P14618 1/20 0.32
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28899979 1.00 MAPK14 (0.39) MAPK14CACNA1BAPBA1TDP1ZAP70
SCHEMBL28465739 0.89 MAPK14 (0.36) MAPK14RXFP1CTSABRD4SDHB
SCHEMBL29594311 0.89 MAPK14 (0.36) MAPK14RXFP1CTSABRD4SDHB
SCHEMBL27806129 0.86 CACNA1B (0.38) CACNA1BAPBA1TDP1SDHBLRRK2
SCHEMBL29593415 0.86 CACNA1B (0.38) CACNA1BAPBA1TDP1SDHBLRRK2
SCHEMBL1063918 0.84 HSP90AB1 (0.43) MAPK14CACNA1BAPBA1TDP1ZAP70
SCHEMBL28461712 0.81 KCNH2 (0.37) MAPK14BRD4PTGS2
SCHEMBL29594254 0.81 KCNH2 (0.37) MAPK14BRD4PTGS2
SCHEMBL28464519 0.81 PTGS2 (0.37) MAPK14RXFP1BRD4SDHBPTGS2
SCHEMBL29593211 0.81 PTGS2 (0.37) MAPK14RXFP1BRD4SDHBPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-09-24 CN disclosed
CN-114732910-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-08-23 CN disclosed
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed
CN-111601593-B P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-04-15 CN disclosed